Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels

Frontiers in Microbiology

Volumn 5, Issue OCT, 2014, Pages

  Meira, Cristina S ^a   Pereira Chioccola, Vera L ^a   Vidal, José E ^b   de Mattos, Cinara C Brandão ^c   Motoie, Gabriela ^a   Costa Silva, Thais A ^a   Gava, Ricardo ^a   Frederico, Fábio B ^d   de Mattos, Luiz C ^c   Dantas, Daniel Soares de Sousa ^e   de Andrade, Tatiana Pimentel ^e   Batista, ^e   Kassab, Maria Jose Oliveira ^e   Bazzi, Munir ^e   Prestes, Daniel Paffili ^e   Strelow, Vanessa Levien ^e   Massaia, Adriana Weinfeld ^e   Audi, Daniele ^e   Lago, Mariana Martins ^e   Moreira, Carlos Henrique Valente ^e   Barbosa, Amanda Pires ^c   Neto, Plínio Pereira Martins ^c   Almeida, Gildásio Castello ^c   Previato, Mariana ^c   more..

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^c FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^d HOSPITAL DE BASE   (Brazil)

^e Toxoplasma Research Group   (Brazil)

Author keywords

Cerebral toxoplasmosis and AIDS; Cytokines; Immune response; Ocular toxoplasmosis; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; AIDS PATIENT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CEREBRAL TOXOPLASMOSIS; CHOROID; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OCULAR TOXOPLASMOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; RETINA INJURY; TOXOPLASMA GONDII;

EID: 84987837702     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00492     Document Type: Article

References (43)

1. Ajzenberg, D., Banuls, A. L., Su, C., Dumètre, A., Demar, M., Carme, B., et al. (2004). Genetic diversity, clonality and sexuality in Toxoplasma gondii.Int. J. Parasitol. 34, 1185-1196. doi: 10.1016/j.ijpara.2004.06.007
2. Beaman, M. H., Wong, S. Y., and Remington, J. S. (1992). Cytokines, Toxoplasma and intracellular parasitism. Immunol. Rev. 127, 97-117. doi: 10.1111/j.1600-065X.1992.tb01410.x
3. Burg, J. L., Grover, C. M., Pouletty, P., and Boothroyd, J. C. (1989). Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 27, 1787-1792.
4. Carruthers, V. B., and Suzuki, Y. (2007). Effects of Toxoplasma gondii infection on the brain. Schizophr. Bull. 33, 745-751. doi: 10.1093/schbul/sbm008
5. Colombo, F. A., Vidal, J. E., Penalva de Oliveira, A. C., Hernandez, A. V., Bonasser-Filho, F., Nogueira, R. S., et al. (2005). Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J. Clin. Microbiol. 43, 5044-5047. doi: 10.1128/JCM.43.10.5044-5047.2005
6. Costa-Silva, T. A., Borges, M. M., Galhardo, C. S., and Pereira-Chioccola, V. L. (2012a). Immunization with excreted/secreted proteins in AS/n mice activating cellular and humoral response against Toxoplasma gondii infection. Acta Trop. 124, 203-209. doi: 10.1016/j.actatropica.2012.08.013
7. Costa-Silva, T. A., Meira, C. S., Frazzatti-Gallina, N., and Pereira-Chioccola, V. L. (2012b). Toxoplasma gondii antigens: recovery analysis of tachyzoites cultivated in Vero cell maintained in serum free medium. Exp. Parasitol. 130, 463-469. doi: 10.1016/j.exppara.2012.01.005
8. Delair, E., Latkany, P., Noble, A. G., Rabiah, P., McLeod, R., and Brezin, A. (2011). Clinical manifestations of ocular toxoplasmosis. Ocul. Immunol. Inflamm. 19, 91-102. doi: 10.3109/09273948.2011.564068
9. de-la-Torre, A., Pfaff, A. W., Grigg, M. E., Villard, O., Candolfi, E., and Gomez-Marin, J. E. (2014). Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis. Cytokine 68, 23-31. doi: 10.1016/j.cyto.2014.03.005
10. de-la-Torre, A., Sauer, A., Pfaff, A. W., Bourcier, T., Brunet, J., Speeg-Schatz, C., et al. (2013). Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels. PLoS Negl. Trop. Dis. 21:e2541. doi: 10.1371/journal.pntd.0002541
11. Denkers, E. Y., and Gazzinelli, R. T. (1998). Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11, 569-588.
12. Dubey, J. P., Lago, E. G., Gennari, S. M., Su, C., and Jones, J. L. (2012). Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 139, 1375-1424. doi: 10.1017/S0031182012000765
13. Ferreira, A. I. C., De Mattos, C. C., Frederico, F. B., Meira, C. S., Almeida, G. C. Jr., Nakashima, F., et al. (2014). Risk factors for ocular toxoplasmosis in Brazil. Epidemiol. Infect. 142, 142-148. doi: 10.1017/S0950268813000526
14. Ferreira, I. M., Vidal, J. E., de Mattos, C. C., de Mattos, L. C., Qu, D., Su, C., et al. (2011). Toxoplasma gondii isolates: multilocus RFLP-PCR genotyping from human patients in Sao Paulo State, Brazil identified distinct genotypes. Exp. Parasitol. 129, 190-195. doi: 10.1016/j.exppara.2011.06.002
15. Gaddi, P. J., and Yap, G. S. (2007). Cytokine regulation of immunopathology in toxoplasmosis. Immunol. Cell Biol. 85, 155-159. doi: 10.1038/sj.icb.7100038
16. Garweg, J. G., and Candolfi, E. (2009). Immunopathology in ocular toxoplasmosis: facts and clues. Mem. Inst. Oswaldo Cruz 104, 211-220. doi: 10.1590/S0074-02762009000200014
17. Ghasemi, H., Ghazanfari, T., Yaraee, R., Owlia, R., Hassan, Z. M., and Faghihzadeh, S. (2012). Roles of IL-10 in ocular inflammations: a review. Ocul. Immunol. Inflamm. 20, 406-418. doi: 10.3109/09273948.2012.723109
18. Gilbert, R. E., Freeman, K., Lago, E. G., Bahia-Oliveira, L. M., Tan, H. K., Wallon, M., et al. (2008). European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2:e277. doi: 10.1371/journal.pntd.0000277
19. Goldszmid, R. S., Caspar, P., Rivollier, A., White, S., Dzutsev, A., Hieny, S., et al. (2012). NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 36, 1047-1059. doi: 10.1016/j.immuni.2012.03.026
20. Hoti, S. L., and Tandon, V. (2011). Ocular parasitoses and their immunology. Ocul. Immunol. Inflamm. 19, 385-396. doi: 10.3109/09273948.2011.626141
21. Kumar, A., Angel, J. B., Daftarian, M. P., Parato, K., Cameron, W. D., Filion, L., et al. (1998). Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: association of IL-10 production with CD28-mediated immune responsiveness. Clin. Exp. Immunol. 114, 78-86. doi: 10.1046/j.1365-2249.1998.00689.x
22. Lin, D. S., and Bowman, D. D. (1992). Toxoplasma gondii: an AIDS enhancing cofactor. Med. Hypotheses 39, 140-142. doi: 10.1016/0306-9877(92)90174-B
23. Mack, D. G., Johnson, J. J., Roberts, F., Roberts, C. W., Estes, R. G., David, C., et al. (1999). HLA-class II genes modify outcome of Toxoplasma gondii infection. Int. J. Parasitol. 29, 1351-1358. doi: 10.1016/S0020-7519(99)00152-6
24. Mattos, C. C., Meira, C. S., Ferreira, A. I., Frederico, F. B., Hiramoto, R. M., and Jr, G. C., et al. (2011). Contribution of laboratory methods in diagnosing clinically suspected ocular toxoplasmosis in Brazilian patients. Diagn. Microbiol. Infect. Dis. 70, 362-366. doi: 10.1016/j.diagmicrobio.2011.02.002
25. Meira, C. S., Costa-Silva, T. A., Vidal, J. E., Ferreira, I. M., Hiramoto, R. M., and Pereira-Chioccola, V. L. (2008). Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigens in cerebral toxoplasmosis diagnosis in human immunodeficiency virus-infected patients. J. Med. Microbiol. 57, 845-850. doi: 10.1099/jmm.0.47687-0
26. Meira, C. S., Vidal, J. E., Costa-Silva, T. A., Frazatti-Gallina, N., and Pereira-Chioccola, V. L. (2011). Immunodiagnosis in cerebrospinal fluid of cerebral toxoplasmosis and HIV-infected patients using Toxoplasma gondii excreted/secreted antigens. Diagn. Microbiol. Infect. Dis. 71, 279-285. doi: 10.1016/j.diagmicrobio.2011.07.008
27. Meira, C. S., Vidal, J. E., Costa-Silva, T. A., Motoie, G., Gava, R., Hiramoto, R. M., et al. (2013). IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients. J. Immunol. Methods 395, 21-28. doi: 10.1016/j.jim.2013.06.005
28. Mesquita, R. T., Ziegler, A. P., Hiramoto, R. M., Vidal, J. E., and Pereira-Chioccola, V. L. (2010). Real-time quantitative PCR in cerebral toxoplasmosis diagnosis of Brazilian human immunodeficiency virus-infected patients. J. Med. Microbiol. 59, 641-647. doi: 10.1099/jmm.0.016261-0
29. Neyer, L. E., Grunig, G., Fort, M., Remington, J. S., Rennick, D., and Hunter, C. A. (1997). Role of interleukin-10 in regulation of T cell dependent and T cell independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65, 1675-1682.
30. Nijhawan, R., Bansal, R., Gupta, N., Beke, N., Kulkarni, P., and Gupta, A. (2013). Intraocular cysts of Toxoplasma gondii in patients with necrotizing retinitis following periocular/intraocular triamcinolone injection. Ocul. Immunol. Inflamm. 21, 396-399. doi: 10.3109/09273948.2013.810276
31. Olariu, T. R., Remington, J. S., McLeod, R., Alam, A., and Montoya, J. G. (2011). Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr. Infect. Dis. J. 30, 1056-1061. doi: 10.1097/INF.0b013e3182343096
32. Pereira-Chioccola, V. L., Vidal, J. E., and Su, C. (2009). Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiol. 4, 1363-1379. doi: 10.2217/fmb.09.89
33. Pfaff, A., de-la-Torre, A., Rochet, E., Brunet, J., Sabou, M., Sauer, A., et al. (2014). New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis. Int. J. Parasitol. 44, 99-107. doi: 10.1016/j.ijpara.2013.09.007
34. Portegies, P., Solod, L., Cinque, P., Chaudhuri, A., Begovac, J., Everall, I., et al. (2004). Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur. J. Neurol. 11, 297-304. doi: 10.1111/j.1468-1331.2004.00856.x
35. Robert-Gangneux, F., and Dardé, M. L. (2012). Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 25, 264-296. doi: 10.1128/CMR.05013-11
36. Sarciron, M. E., and Guerardi, A. (2000). Cytokines involved in Toxoplasmic encephalitis. Scand. J. Immunol. 52, 534-543. doi: 10.1046/j.1365-3083.2000.00817.x
37. Sullivan, W. J. Jr., and Jeffers, V. (2012). Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol. Rev. 36, 717-733. doi: 10.1111/j.1574-6976.2011.00305.x
38. Talabani, H., Mergey, T., Year, H., Delair, E., Brézin, A. P., Langsley, G., et al. (2010). Factors of occurrence of ocular toxoplasmosis. A review. Parasite 17, 177-182. doi: 10.1051/parasite/2010173177
39. Vallochi, A. L., Nakamura, M. V., Schlesinger, D., Martins, M. C., Silveira, C., Belfort, R., et al. (2002). Ocular toxoplasmosis: more than just what meets the eye. Scand. J. Immunol. 55, 324-328. doi: 10.1046/j.1365-3083.2002.01052.x
40. Vidal, J. E., and Oliveira, A. C. (2013). AIDS-related cerebral toxoplasmosis in São Paulo State, Brazil: marked improvements in the highly active antiretroviral therapy-era but the challenges continue. Braz. J. Infect. Dis. 17, 379-380. doi: 10.1016/j.bjid.2012.10.030
41. Wallace, G. R., and Stanford, M. R. (2008). Immunity and Toxoplasma retinochoroiditis. Clin. Exp. Immunol. 153, 309-315. doi: 10.1111/j.1365-2249.2008.03692.x
42. Weiss, L. M., and Dubey, J. P. (2009). Toxoplasmosis: a history of clinical observations. Int. J. Parasitol. 39, 895-901. doi: 10.1016/j.ijpara.2009.02.004
43. Yamamoto, J. H., Vallochi, A. L., Silveira, C., Filho, J. K., Nussenblatt, R. B., Cunha-Neto, E., et al. (2000). Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. J. Infect. Dis. 181, 2018-2022. doi: 10.1086/315494